Kenya and Japan announced a new health partnership aimed at boosting domestic production of medicines and medical technologies, expanding clinical research and enhancing the skills of Kenyan health workers.

The collaboration will combine Japanese technology and expertise with Kenya’s universities, research institutes and private sector to develop medicines, diagnostic tools and other health technologies within the country.

Discussions took place at the inaugural Japan–Kenya Health Cooperation Meeting, chaired by Principal Secretary for Medical Services Dr Ouma Oluga, covering research, clinical trials, manufacturing, financing, workforce development and technology access.

A priority is to strengthen early‑stage research and clinical trials, creating clearer pathways for turning laboratory discoveries into marketable medicines, diagnostics and technologies for patients.

The partnership will also fund specialised training and simulation‑based learning for health workers, and foster stronger links between universities and hospitals to improve practical skills and promote innovation.

Health financing was another key agenda, with both sides exploring sustainable financing, domestic resource mobilisation and health technology assessment to evaluate the cost‑effectiveness of new products as Kenya expands universal health coverage.

Beyond equipment supply, the cooperation seeks to build long‑term capacity in skills, institutions, research and infrastructure, positioning Kenya as a regional hub for health research, manufacturing and training.

The initiative aligns with Kenya’s broader push to expand local manufacturing and create a more resilient health system, complementing ongoing efforts such as the Kenya BioVax Institute’s vaccine and biologics production programme.

BioVax aims to produce vaccines, diagnostics, insulin and biosimilar medicines locally, supporting research, technology transfer and product development as part of the country’s strategy to reduce reliance on imports.